Literature DB >> 17440765

Renal and urologic manifestations of pediatric condition falsification/Munchausen by proxy.

Kenneth W Feldman1, Marc D Feldman, Richard Grady, Mark W Burns, Ruth McDonald.   

Abstract

Renal and urologic problems in pediatric condition falsification (PCF)/Munchausen by proxy (MBP) can pose frustrating diagnostic and management problems. Five previously unreported victims of PCF/MBP are described. Symptoms included artifactual hematuria, recalcitrant urinary infections, dysfunctional voiding, perineal irritation, glucosuria, and "nutcracker syndrome", in addition to alleged sexual abuse. Falsifications included false or exaggerated history, specimen contamination, and induced illness. Caretakers also intentionally withheld appropriately prescribed treatment. Children underwent invasive diagnostic and surgical procedures because of the falsifications. They developed iatrogenic complications as well as behavioral problems stemming from their abuse. A PCF/MBP database was started in 1995 and includes the characteristics of 135 PCF/MBP victims examined by the first author between 1974 and 2006. Analysis of the database revealed that 25% of the children had renal or urologic issues. They were the presenting/primary issue for five. Diagnosis of PCF/MBP was delayed an average of 4.5 years from symptom onset. Almost all patients were victimized by their mothers, and maternal health falsification and somatization were common. Thirty-one of 34 children had siblings who were also victimized, six of whom died. In conclusion, falsifications of childhood renal and urologic illness are relatively uncommon; however, the deceits are prolonged and tortuous. Early recognition and intervention might limit the harm.

Entities:  

Mesh:

Year:  2007        PMID: 17440765     DOI: 10.1007/s00467-007-0431-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  19 in total

Review 1.  The deceit continues: an updated literature review of Munchausen Syndrome by Proxy.

Authors:  Mary S Sheridan
Journal:  Child Abuse Negl       Date:  2003-04

2.  Evaluation of covert video surveillance in the diagnosis of munchausen syndrome by proxy: lessons from 41 cases.

Authors:  D E Hall; L Eubanks; L S Meyyazhagan; R D Kenney; S C Johnson
Journal:  Pediatrics       Date:  2000-06       Impact factor: 7.124

3.  Covert video recordings of life-threatening child abuse: lessons for child protection.

Authors:  D P Southall; M C Plunkett; M W Banks; A F Falkov; M P Samuels
Journal:  Pediatrics       Date:  1997-11       Impact factor: 7.124

4.  Repeated false allegations of sexual abuse presenting to sheriffs: when is it Munchausen by Proxy?

Authors:  H A Schreier
Journal:  Child Abuse Negl       Date:  1996-10

5.  Psychologic morbidity of children subjected to Munchausen syndrome by proxy.

Authors:  T L McGuire; K W Feldman
Journal:  Pediatrics       Date:  1989-02       Impact factor: 7.124

6.  Factitious hematuria with underlying renal abnormalities.

Authors:  R F Salmon; B S Arant; M G Baum; R J Hogg
Journal:  Pediatrics       Date:  1988-09       Impact factor: 7.124

7.  Polle syndrome: children of Munchausen.

Authors:  C M Verity; C Winckworth; D Burman; D Stevens; R J White
Journal:  Br Med J       Date:  1979-08-18

8.  Povidone iodine as a cause of factitious hematuria and abnormal urine coloration in the pediatric emergency department.

Authors:  M D Baker; R N Baldassano
Journal:  Pediatr Emerg Care       Date:  1989-12       Impact factor: 1.454

9.  Exogenous protein as the cause of nephrotic-range proteinuria.

Authors:  J A Mitas
Journal:  Am J Med       Date:  1985-07       Impact factor: 4.965

10.  Munchausen syndrome by proxy: a family affair.

Authors:  A L Mehl; L Coble; S Johnson
Journal:  Child Abuse Negl       Date:  1990
View more
  1 in total

Review 1.  Fabricated or induced illness in the oral cavity in children. A systematic review and personal experience.

Authors:  Dorota Olczak-Kowalczyk; Beata Wolska-Kusnierz; Ewa Bernatowska
Journal:  Cent Eur J Immunol       Date:  2015-04-22       Impact factor: 2.085

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.